AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 41 filers reported holding AEVI GENOMIC MEDICINE INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | -100.0% | 500 | -75.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 2,000 | -4.3% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 2,089 | +4.4% | 0.00% | – |
| Q2 2018 | $2,000 | -50.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | +100.0% | 2,000 | -1.2% | 0.00% | – |
| Q4 2017 | $2,000 | -33.3% | 2,025 | 0.0% | 0.00% | – |
| Q3 2017 | $3,000 | 0.0% | 2,025 | +1.2% | 0.00% | – |
| Q2 2017 | $3,000 | -50.0% | 2,000 | -36.8% | 0.00% | – |
| Q1 2017 | $6,000 | -68.4% | 3,165 | -14.7% | 0.00% | – |
| Q4 2016 | $19,000 | – | 3,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|